PFS
IBB icon

Prospera Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Prospera Financial Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
2,715
+16
+0.6% +$2.75K 0.01% 1026
2026
Q1 		$456K Buy
2,699
+391
+17% +$66.9K 0.01% 1026
2025
Q4 		$390K Sell
2,308
-91
-4% -$14.8K 0.01% 1027
2025
Q3 		$346K Buy
2,399
+593
+33% +$80.9K 0.01% 1095
2025
Q2 		$229K Sell
1,806
-643
-26% -$78.9K ﹤0.01% 1218
2025
Q1 		$313K Sell
2,449
-284
-10% -$38.5K 0.01% 974
2024
Q4 		$361K Sell
2,733
-147
-5% -$20.7K 0.01% 857
2024
Q3 		$419K Buy
2,880
+152
+6% +$22K 0.01% 782
2024
Q2 		$374K Sell
2,728
-482
-15% -$64.3K 0.01% 824
2024
Q1 		$440K Buy
3,210
+428
+15% +$58.5K 0.01% 745
2023
Q4 		$378K Sell
2,782
-466
-14% -$56.9K 0.01% 749
2023
Q3 		$397K Buy
3,248
+1,406
+76% +$179K 0.02% 688
2023
Q2 		$234K Sell
1,842
-82
-4% -$10.7K 0.01% 903
2023
Q1 		$249K Sell
1,924
-225
-10% -$29.5K 0.01% 843
2022
Q4 		$282K Sell
2,149
-138
-6% -$17.8K 0.01% 735
2022
Q3 		$267K Sell
2,287
-229
-9% -$28.4K 0.01% 686
2022
Q2 		$296K Sell
2,516
-87
-3% -$10.3K 0.02% 639
2022
Q1 		$339K Sell
2,603
-341
-12% -$44.4K 0.01% 713
2021
Q4 		$449K Sell
2,944
-324
-10% -$50.2K 0.02% 606
2021
Q3 		$529K Sell
3,268
-321
-9% -$54K 0.03% 519
2021
Q2 		$588K Buy
3,589
+6
+0.2% +$924 0.03% 487
2021
Q1 		$540K Sell
3,583
-767
-18% -$122K 0.03% 470
2020
Q4 		$659K Buy
4,350
+3,134
+258% +$448K 0.05% 367
2020
Q3 		$165K Sell
1,216
-2,324
-66% -$315K 0.06% 279
2020
Q2 		$484K Buy
3,540
+937
+36% +$119K 0.04% 358
2020
Q1 		$281K Buy
+2,603
New +$300K 0.03% 406
2019
Q1 		– Sell
-3,706
Closed -$359K – 374
2018
Q4 		$359K Buy
3,706
+1,859
+101% +$197K 0.07% 253
2018
Q3 		$215K Buy
+1,847
New +$217K 0.04% 381
2017
Q1 		– Sell
-3,306
Closed -$297K – 402
2016
Q4 		$297K Buy
+3,306
New +$301K 0.06% 273

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Prospera Financial Services's IBB Position: Q2 2026 in Review

Prospera Financial Services increased its iShares Biotechnology ETF (IBB) stake by 0.59% in Q2 2026, buying an estimated $2.75K and bringing the position to 2,715 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #1026.

Prospera Financial Services first reported a position in IBB in Q4 2016 and has held it in 29 quarters since. The position peaked at $659K in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Prospera Financial Services held 2,715 shares of iShares Biotechnology ETF worth $516K as of Q2 2026.
  • Prospera Financial Services bought 16 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.75K.
  • iShares Biotechnology ETF made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1026 holding.
  • Prospera Financial Services first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 29 quarters since.
  • Prospera Financial Services's iShares Biotechnology ETF position peaked at $659K in Q4 2020.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.